<DOC>
	<DOCNO>NCT00156819</DOCNO>
	<brief_summary>This research study compare treatment effect three different asthma medication asthma subject whose asthma well control take fluticasone , inhale corticosteroid . The treatment fluticasone , montelukast ( anti ? leukotriene drug ) , combination therapy fluticasone salmeterol ( long-acting beta-agonist ) . Fluticasone , montelukast , combination therapy fluticasone salmeterol ( Advair DiskusÂ® ) approve treatment asthma . We look whether three treatment equally effective reduce number severity asthma attack subject mild moderately severe asthma .</brief_summary>
	<brief_title>The Leukotriene Modifier Or Corticosteroid Corticosteroid-Salmeterol Trial</brief_title>
	<detailed_description>This trial attempt investigate whether asthmatic patient well control low-dose twice daily inhale corticosteroid ( ICS ) therapy safely switch mode controller therapy without loss asthma control . Patients demonstrate good control twice-daily low-dose ICS randomize one three treatment group : once-daily low-dose ICS ( fluticasone ) , leukotriene receptor antagonist ( montelukast ) , once-daily combination therapy ( fluticasone-salmeterol ) .</detailed_description>
	<mesh_term>Salmeterol Xinafoate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>physiciandiagnosed asthma age 6 old prebronchodilator force expiratory volume ( FEV1 ) least 60 % predicted betaagonist reversibility OR airways hyperreactivity methacholine challenge Juniper Asthma Control Score 1.5 great daily controller good current health current past smoking ( great 20 packyears ) chronic current oral steroid therapy pregnancy , lack effective contraception ( appropriate ) , lactation</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Asthma Control</keyword>
</DOC>